Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...

Imagine you're looking at millions upon millions of mysterious genetic mutations. With CRISPR gene-editing technology, a ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

New technologies often get pushback from sectors of society. In the 19th century people feared the unknown effects on the ...

Corteva invests $25M in N.C. startup to boost gene-editing efforts, with Pioneer in Johnston playing a big role in making ...

The funds will support ongoing work on Fulcrum, Pairwise's gene-editing platform and efforts to create edited crops with specific traits.

A leading scientist is welcoming the end to a gene technology ban, saying New Zealand has missed opportunities because of outdated rules. The government believes lifting the nearly 30-year ...

The future of CRISPR involves clinical trials focused on treatment for blood diseases and cancers, cardiovascular disease, ...

Investments from this funding round will be used to scale Pairwise’s innovative product pipeline, including seedless berries and pitless cherries.

Supporters of the technology say it could reduce animal diseases and suffering and lead to the use of fewer antibiotics. They ...

The startup’s technology combines an AAV — a common gene therapy delivery tool — with an immunotherapy approach now widely ...

Within bacterial cells, specialized immune systems known as retrons fend off viral attacks. But that's not all they can do.